| Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial 2023 · EPP-AF (propolis) · Adults aged 18–80 hospitalized with SARS-CoV-2 infection (COVID-19), not receiving mechanical ventilation at randomization | 300 mg | 10 days | 98 |
| Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial 2021 · EPP-AF 400 mg/day · Hospitalized adults over 18 with PCR-confirmed SARS-CoV-2 infection and symptom onset within 14 days of randomization | 400 mg | 7 days | 40 |
| Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial 2021 · EPP-AF 800 mg/day · Hospitalized adults over 18 with PCR-confirmed SARS-CoV-2 infection and symptom onset within 14 days of randomization | 800 mg | 7 days | 42 |
| Brazilian Propolis Intake Decreases Body Fat Mass and Oxidative Stress in Community-Dwelling Elderly Females: A Randomized Placebo-Controlled Trial 2023 · propolis group (PRO) · Healthy postmenopausal females aged 65 years or older, independent in daily life | 454 mg | 12 weeks | 39 |
| The effects of propolis supplementation on high-sensitivity C-reactive protein, testosterone hormone, and metabolic profile in women with polycystic ovary syndrome: A randomized, triple-blinded, placebo-controlled clinical trial 2023 · propolis group · Women with polycystic ovary syndrome; age range not reported | 500 mg | 12 weeks | 30 |
| Oral Propolis, Nutritional Status and Quality of Life with Chemotherapy for Breast Cancer: A Randomized, Double-Blind Clinical Trial 2022 · propolis · Patients with breast cancer receiving chemotherapy | 500 mg | 90 days | — |
| A randomized, double-blind, placebo-controlled study evaluating the efficacy of propolis and N-acetylcysteine in exacerbations of chronic obstructive pulmonary disease 2022 · AS-1,200 · Patients with frequent-exacerbation COPD following an acute exacerbation | 160 mg | 90 days | — |
| Brazilian Green Propolis Prevents Cognitive Decline into Mild Cognitive Impairment in Elderly People Living at High Altitude 2018 · propolis · elderly people (average age 72.8 years) living at high altitude | 830 mg | 2 years | 30 |
| A randomized, double-blind, placebo-controlled study evaluating the efficacy of propolis and N-acetylcysteine in exacerbations of chronic obstructive pulmonary disease 2022 · AS-600 · Patients with frequent-exacerbation COPD following an acute exacerbation | 80 mg | 90 days | — |
| Propolis mouthwash for preventing radiotherapy-induced mucositis in patients with nasopharyngeal carcinoma 2022 · Experimental group · Patients with nasopharyngeal carcinoma receiving radiotherapy | 21 mL | 6 weeks | 10 |
| The effect of propolis plus Hyoscyamus niger L. methanolic extract on clinical symptoms in patients with acute respiratory syndrome suspected to COVID-19: A clinical trial 2021 · intervention · Patients with acute respiratory syndrome suspected to be COVID-19; age range and sex not reported | 1.35 g | 6 days | — |
| The Effect of Iranian Propolis on Glucose Metabolism, Lipid Profile, Insulin Resistance, Renal Function and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Clinical Trial 2019 · propolis group · Adults aged 35–85 with type 2 diabetes mellitus receiving oral hypoglycemic agents | 1 g | 90 days | 50 |
| Cumulative effects of exercise training and consumption of propolis on managing diabetic dyslipidemia in adult women: a single-blind, randomized, controlled trial with pre-post-intervention assessments 2023 · SUPP group · Women aged 40–60 with type 2 diabetes and dyslipidemia | 1.5 g | 8 weeks | 15 |
| Cumulative effects of exercise training and consumption of propolis on managing diabetic dyslipidemia in adult women: a single-blind, randomized, controlled trial with pre-post-intervention assessments 2023 · EXR + SUPP group · Women aged 40–60 with type 2 diabetes and dyslipidemia | 1.5 g | 8 weeks | 15 |
| Efficacy and safety of Atusin(®) CAP in the treatment of acute uncomplicated bronchitis in the primary care setting: a multi-center, randomized, double-blind, placebo-controlled study (AABA) 2025 · verum group · Adults with acute uncomplicated bronchitis; mean age 39.5 years, 66.5% female | 30 mg | 10 days | 155 |
| Effect of propolis on mood, quality of life, and metabolic profiles in subjects with metabolic syndrome: a randomized clinical trial 2023 · propolis group · Adults aged 20–60 years with metabolic syndrome | 500 mg | 12 weeks | 33 |
| Propolis Improves Periodontal Status and Glycemic Control in Patients With Type 2 Diabetes Mellitus and Chronic Periodontitis: A Randomized Clinical Trial 2016 · propolis + SRP group · Patients with type 2 diabetes mellitus and chronic periodontitis; age and sex not specified | 400 mg | 26 weeks | 24 |
| Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation 2022 · propolis · Patients with NAFLD confirmed by ultrasonography; age and sex not specified | 510 mg | 8 weeks | 23 |
| Propolis increases Foxp3 expression and lymphocyte proliferation in HIV-infected people: A randomized, double blind, parallel-group and placebo-controlled study 2021 · propolis · Asymptomatic people living with HIV/AIDS receiving antiretroviral therapy; adults, age range and sex not specified | 500 mg | 90 days | 20 |
| Propolis consumption by asymptomatic HIV-individuals: Better redox state? A prospective, randomized, double-blind, placebo-controlled trial 2023 · propolis · People with asymptomatic HIV and suppressed viral load receiving combined antiretroviral therapy; age and sex not specified | 500 mg | 90 days | 20 |
| Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial 2019 · propolis group · Adults aged 18–90 with chronic kidney disease, eGFR 25–70 ml/min per 1.73 m² and proteinuria | 500 mg | 1 year | 18 |
| Detoxification effects of aloe polysaccharide and propolis on the urinary excretion of metabolites in smokers 2019 · Propolis · Smokers smoking at least 20 cigarettes per day | 600 mg | 4 weeks | 10 |
| The effect of Brazilian Green Propolis extract on inflammation in patients with chronic kidney disease on peritoneal dialysis: A randomised double-blind controlled clinical trial 2023 · propolis group · Adults with chronic kidney disease on peritoneal dialysis | 400 mg | 60 days | 10 |
| Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial 2021 · propolis group · Patients with nonalcoholic fatty liver disease (NAFLD); age and sex not specified | 500 mg | 120 days | — |
| Anti-hyperglycemic effects of propolis or metformin in type 2 diabetes mellitus 2023 · propolis · Pharmacological treatment-naïve patients with type 2 diabetes mellitus | 600 mg | 12 weeks | — |
| Propolis supplementation improves glycemic and antioxidant status in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study 2019 · propolis · Adults aged 30–55 with type 2 diabetes | 1.5 g | 8 weeks | 31 |
| Brazilian green propolis effect on biochemical parameters and dietary intake in people living with diabetes 2025 · G1 (Phase 1; BrGrProp) · People living with diabetes; age and sex not reported | 1 g | 30 days | 31 |
| Brazilian green propolis effect on biochemical parameters and dietary intake in people living with diabetes 2025 · G2 (Phase 2; BrGrProp) · People living with diabetes; age and sex not reported | 1 g | 30 days | 22 |
| The effects of propolis on pro-oxidant-antioxidant balance, glycemic control, and quality of life in chronic kidney disease: a randomized, double-blind, placebo-controlled trial 2023 · propolis group · Adults aged 20–80 with chronic kidney disease, eGFR 30–89 mL/min per 1.73 m² | 250 mg | 90 days | 17 |
| The effects of high-intensity interval training and Iranian propolis extract on serum levels of TRPV4 and CYP2E1 proteins in patients with nonalcoholic fatty liver 2024 · Propolis supplement · Overweight or obese adults with NAFLD grades 2–3, diagnosed by ultrasound and elevated ALT and AST; ages 42–46 years in the reported group data; sex not specified for this arm | 150 mg | 8 weeks | 8 |
| The effects of high-intensity interval training and Iranian propolis extract on serum levels of TRPV4 and CYP2E1 proteins in patients with nonalcoholic fatty liver 2024 · HIIT + Propolis · Overweight or obese adults with NAFLD grades 2–3, diagnosed by ultrasound and elevated ALT and AST; ages 45–46 years in the reported group data; sex not specified for this arm | 150 mg | 8 weeks | 8 |
| Brazilian Green Propolis Improves Antioxidant Function in Patients with Type 2 Diabetes Mellitus 2016 · Brazilian green propolis group · Adults aged 35–78 with type 2 diabetes mellitus | 900 mg | 18 weeks | — |
| Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial 2017 · intervention group (IG) · Patients with type 2 diabetes; age and sex not reported | 900 mg | 12 weeks | — |
| The effect of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis: A double-blind, placebo, controlled randomized clinical trial 2023 · intervention group · Women with rheumatoid arthritis | 1 g | 12 weeks | — |
| Effects of Melatonin and Propolis Supplementation on Inflammation, Oxidative Stress, and Clinical Outcomes in Patients with Primary Pneumosepsis: A Randomized Controlled Clinical Trial 2022 · propolis alone · Patients with primary pneumosepsis; age and sex not reported | 1 g | — | — |
| Propolis as an adjunctive therapy for treatment of uncomplicated cystitis in women: A randomized double-blind placebo-controlled trial 2024 · propolis group · women with uncomplicated cystitis | 1 g | 7 days | — |
| Detoxification effects of aloe polysaccharide and propolis on the urinary excretion of metabolites in smokers 2019 · APS and propolis mixture · Smokers smoking at least 20 cigarettes per day | 180 mg | 4 weeks | 10 |
| Effects of Melatonin and Propolis Supplementation on Inflammation, Oxidative Stress, and Clinical Outcomes in Patients with Primary Pneumosepsis: A Randomized Controlled Clinical Trial 2022 · propolis plus melatonin · Patients with primary pneumosepsis; age and sex not reported | 1 g | — | — |
| Apitherapy with Royal Jelly and Green Propolis EPP-AF(®) Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis 2025 · Royal jelly + green propolis group (RJ + GP) · Men and women aged 18–75 with chronic kidney disease undergoing hemodialysis | 500 mg | 60 days | 28 |
| Effects of a Functional Food Mixture on Patients Undergoing Hemodialysis: Preliminary Results Highlighting the Modulation of Uremic Toxins Derived From Microbiota and Antioxidant Markers 2025 · intervention group · Adults with chronic kidney disease undergoing hemodialysis | 110 mg | 8 weeks | 17 |